StudyManager Releases Reveal Version 3.1
Expanded Business Management and Productivity Tools for Research Sites
Reveal 3.1 allows research organizations to centralize study information, organize research activities, and increase recruitment and financial performance.
Strong Market Response to Reveal and Personalized Service
StudyManager has seen a 40% increase in Reveal sales in the second half of 2010, compared to the first half of the year. Growth is expected to accelerate further in 2011, as StudyManager pairs its Reveal cloud solution with an on-premises option and continues to expand features and services. With Reveal, each customer gets a dedicated trainer who builds a training plan around the customer’s needs and objectives.
Improving the Research Site "Bottom Line"
Reveal is built on the feedback and experience of StudyManager's customers, and the company's nearly 20 years in the field. Then, Reveal's decision support tools can have a big impact on the bottom line, helping sites negotiate more favorable contracts, make enrollment course corrections, and ensure they get paid for all study activity.
Reveal features focus on helping sites centralize study information, and:
- Improve clinical trial recruitment and enrollment results
- Negotiate more favorable contracts
- Ensure payment for all study activity–including items that have been historically difficult for sites to track such as screen-fails, holdbacks, and one-time fees
- Support clinical trial compliance efforts including federal patient privacy regulations, clinical compliance with sponsors’ protocols, and billing compliance to eliminate potential for double-billing of multiple payers
- Develop best practices and automate daily tasks to save time, reduce stress, and cut down on mistakes
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025